Author

E. Alici

h-index 32 View on Semantic Scholar

We have 3 of 150 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Extracellular vesicle secretome from mesenchymal stromal cells prevents post-ischemic heart failure by targeting cardiac fibrosis.

A clinically approved PDGFRβ-targeted PET-imaging platform for longitudinal assessment of fibrotic activity in STEMI patients and preliminary observations suggest that myofibroblast activation persists for up to 2 months after STEMI in selected patients establish a translational therapeutic-diagnostic framework for ind...

Karl-Henrik Grinnemo, Ken Braesch-Andersen, Johan O. Wedin et al. · Cell Stem Cell · 1 citation

Open access Aug 2026

Oncolytic HSV1716 attenuates tumor-killing activity of infected primary NK cells

It is demonstrated that primary human NK cells are infected by HSV1716 and undergo functional and phenotypic changes, leading to a diminished cytotoxic capacity.

K. Susek, D. Holla, C. Marsal et al. · Frontiers in Immunology · 0 citations

Review Aug 2026

Accelerating Translation of NK Cell Therapies to the Clinic: A European Perspective

Addressing challenges facing the clinical translation of NK cell therapies was one of the issues discussed in the NK & ILC Symposium that took place in Freiburg, Germany from March 11 to 13, 2026, as the annual meeting of the NK & ILC study group of the German Society for Immunology.

L. Knapp, Katharina Sophie Fischer, Janika Sosat et al. · Human Gene Therapy · 0 citations